Abstract
Objective:
Oxygen toxicity is thought to contribute to the development of bronchopulmonary dysplasia (BPD). Oxidant injury leads to formation of F2-isoprostanes (F2-IsoP). We hypothesized that urinary excretion of the stable metabolite of F2-IsoP, 8-iso-PGF2α, would be higher in infants who develop BPD than those who did not.
Methods:
Forty infants <30-weeks gestational age (GA) were enrolled, 24 infants with BPD and 16 without BPD. Urine specimens were collected weekly and stored at −80°C until analyzed. Urinary 8-iso-PGF2α was measured by gas chromatography/mass spectrometry (GC-MS) and normalized to creatinine excretion.
Results:
GA and birth weight (BW) were lower in infants who developed BPD than those who did not. Urinary 8-iso-PGF2α levels in the first or third weeks of age were not significantly different between the two groups.
Conclusion:
Urinary excretion of 8-iso-PGF2α in early postnatal life in preterm infants is not correlated with the development of BPD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Northway Jr WH, Rosan RC, Porter DY . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357–368.
Bancalari E, del Moral T . Bronchopulmonary dysplasia and surfactant. Biol Neonate 2001; 80 (Suppl 1): 7–13.
Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.
Frank L, Groseclose EE . Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984; 18: 240–244.
O'Donovan DJ, Fernandes CJ . Free radicals and diseases in premature infants. Antioxid Redox Signal 2004; 6: 169–176.
Morrow JD, Roberts LJ . The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002; 166 (12 Part 2): S25–30.
Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA . Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158: 1709–1714.
Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ . Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216–220.
Ciabattoni G, Davi G, Collura M, Iapichino L, Pardo F, Ganci A et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 2000; 162 (4 Part 1): 1195–1201.
Cracowski JL, Cracowski C, Bessard G, Pepin JL, Bessard J, Schwebel C et al. Increased lipid peroxidation in patients with pulmonary hypertension. Am J Respir Crit Care Med 2001; 164: 1038–1042.
Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R et al. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 1999; 269: 326–331.
Stier C, Schweer H, Jelinek J, Watzer B, Seyberth HW, Leonhardt A . Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F2-isoprostanes and 8-epi-prostaglandin F2alpha. J Pediatr Gastroenterol Nutr 2001; 32: 137–141.
Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R . Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004; 56: 88–93.
Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA . Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci (Lond) 1996; 91: 711–718.
Roberts LJ, Morrow JD . Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505–513.
Bessard J, Cracowski JL, Stanke-Labesque F, Bessard G . Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatogr B Biomed Sci Appl 2001; 754: 333–343.
Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ et al. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation – a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999; 272: 209–215.
Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L . Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004; 37: 724–732.
Acknowledgements
The authors thank Dr Jason Morrow from Vanderbilt University for his assistance with the GC-MS protocol.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reuter, S., O'Donovan, D., Hegemier, S. et al. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia. J Perinatol 27, 303–306 (2007). https://doi.org/10.1038/sj.jp.7211684
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211684